The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related semaglutide-based drugs, Ozempic and Wegovy – since 2022 amid unprecedented demand.
The end of a shortage of popular weight-loss drugs may mean many people lose access to them
Related Posts
-
Iowa State Fair police offer advice for finding lost children
A mom reunited with her child at the Iowa State Fair highlights the importance of…
-
South Korean and US militaries shorten drills after Trump ordered a reduction
South Korea says the South Korean and U.S. militaries have agreed to shorten their drills…
-
Ames officer injured after patrol vehicle struck on interstate
An Ames police officer is recovering after their patrol vehicle was hit on the interstate…
-
North Polk football reloads, hopes to replicate 2024 success
North Polk went undefeated en route to its first-ever state championship in 2024. The Comets…
Leave a Reply